Halozyme Therapeutics
HALO
#2594
Rank
$5.16 B
Marketcap
$40.68
Share price
-0.12%
Change (1 day)
11.42%
Change (1 year)

Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 month history

Number of shares, 3 month chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Volume in USD (price x number of shares), data since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$1.68 M-93.41%
2023$25.5 M-15.59%
2022$30.2 M38.39%
2021$21.82 M-6.23%
2020$23.27 M-44.23%
2019$41.74 M591.9%
2018$6.03 M-64.48%
2017$16.98 M-5.65%
2016$17.99 M-13.05%
2015$20.7 M-7.81%
2014$22.45 M140.61%
2013$9.33 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$0.12 B$0.58 B๐Ÿ‡บ๐Ÿ‡ธ USA
$45.29 M$0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA
$5.62 M$96.6 M๐Ÿ‡บ๐Ÿ‡ธ USA
$25.9 M$53.82 M๐Ÿ‡ซ๐Ÿ‡ท France
$27.58 M$0.18 B๐Ÿ‡บ๐Ÿ‡ธ USA
$1.29 M$8.77 M๐Ÿ‡บ๐Ÿ‡ธ USA